Gilead Sciences, Inc. (GILD) - Fundamental Analysis
There is a fundamental analysis for GILD stock providing a BUY recommendation for a long-term investing approach.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions.
Check out our report and analysis for the GILD stock below.
Research & Analysis Team | Finance Club UoM
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions.
Check out our report and analysis for the GILD stock below.
Research & Analysis Team | Finance Club UoM